Unichem Laboratories Ltd
Unichem Laboratories Ltd Company History
Unichem Laboratories is engaged in manufacturing of pharmaceutical products.
2002
Enters into Joint Venture with the former Directors of the Bioglan group in Ireland.
Bharat Bio signs marketing alliance with the company to market hepatitis-B, recombinant.
Ind-Swift ties up with the company for Co-marketing pact to co-market finished dosages of its anti-depressant drug citalopram
2002
2003
Registered a net profit increase by around 10.6% in the I quarter at Rs.9.4crs for the same period last year.
Enters into an agreement for the sale of its Animal Healthcare Division to M/s Tetragon Chemie Ltd.
Appoints Mr Prafful D Sheth as the Director of the company.
Unichem Laboratories Ltd, a Mumbai based Rs 475-crore pharmaceutical company, has received ISO 9001 & 14001 certificates
On April 20, 2005 announces commencement of production at its second unit at Baddi, Himachal Pradesh.
2003
2006
Unichem Laboratories enters into agreement with PLIVA inc, USA
2006
2009
Unichem Laboratories Ltd has appointed Mr. Harcharan Singh as Chief Executive - Pharma with effect from March 24, 2009. He shall report to the Board.
2009
2010
Unichem Laboratories Ltd has received approval from US Food & Drug Administration (U.S. FDA) for Hydrochlorothiazide Capsules in the strengths of 12.5 mg.
Unichem Laboratories Ltd strengthened 6.38% to close at Rs 381.15 as the company has received EU GMP certificate from IRISH Medicines Board for the 12 API's manufactured at Company's Roha plant.
Company has splits its Face value of Shares from Rs 5 to Rs 2
2010
2011
Unichem Laboratories Ltd has received approval from US Food & Drug Administration (FDA) for Divalproex Sodium Delayed Release Tablets USP 125mg, 250mg and 500mg (Valproic -Acid Activity).
2011
2012
Mr. Bhagwat S. Dhingra has been appointed as Chief Executive - Domestic Pharma.
"Unichem Laboratories receives ANDA tentative approval from USFDA for IRBESARTAN TABLETS".
Unichem gets tentative nod from USFDA for dementia tablets.
2012
2013
"Unichem Laboratories receives ANDA approval from USFDA for Amlodipine Besylate Tablets".
Unichem Laboratories has recommended Dividend of Rs. 4.50 (225%) per equity share of Rs. 2/- each.
2013
2014
"Unichem Laboratories receives ANDA approval from USFDA for Metronidazole USP Tablets".
Unichem Laboratories has recommended Final Dividend of Rs. 4/- (200%) per equity share of Rs. 2/- each .
2014
2015
Unichem bags ANDA approval for Montelukast Sodium tablets
Acquired API manufacturing unit at Kolhapur
Commissioned expanded capacities at Goa plant
2015
2017
Divested domestic formulation business to Torrent Pharma
2017
2019
Strategic investment in Hyderabad based Optimus Drugs Pvt Ltd. & Optrix Laboratories Pvt Ltd.
New plant site acquired in Goa
Product facility expansions in Ghaziabad and Pithampur
2019
2020
Unichem to acquire 20% stake in Optimus group for Rs 120 cr
2020
2021
New Oral Solid Dosage manufacturing facility commissioned at Goa Plant II
2021
2023
Ipca Laboratories Limited acquires 33. 38% of the paid-up share capital of Unichem
2023
